Assembly Biosciences Inc
ASMB
Get informed when a big investor buys or sells
+ FollowMarket Cap$494.84M
Close$
$0.18
99.3% downside
Current Fair Value
99.3% downsideOvervalued by 99.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $494.84 Million |
|---|---|
| Enterprise Value | $481.20 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.55 |
| Beta | 1.13 |
| Outstanding Shares | 18,853,646 |
Return
| Return on Equity | -0.01% |
|---|---|
| Return on Assets | -0.01% |
| Return on Invested Capital | -2.92% |
Valuation & Multiples
| P/E Ratio | 45.4 |
|---|---|
| PEG | -73.02 |
| Price to Sales | 11.83 |
| Price to Book Ratio | 1.48 |
| Enterprise Value to Revenue | 11.19 |
| Enterprise Value to EBIT | -53.7 |
| Enterprise Value to Net Income | -11458 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.72
Average shareholder expectationRevenue Estimate
$8.60 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.66
Average shareholder expectationRevenue Estimate
$9.07 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6728▲ 67.28% |
|---|---|
| Total Calls | 27,200▲ Infinity% |
| Total Puts | 18,300▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 99.60%▲ 19.32% |
|---|---|
| Total Invested | $515.61M▲ 36.99% |
| Investors Holding | 97▲ 23.00% |
ESG Score
No data